Moleculin Biotech Inc. (MBRX)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
1.83
-0.08 (-4.19%)
At close: Jan 15, 2025, 3:59 PM
1.85
1.09%
After-hours Jan 15, 2025, 04:09 PM EST
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 |
PE Ratio | -0.85 | -1.11 | -5.64 | -3.14 | -2.82 | -2.27 | -3.52 | -5.71 | -60.61 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 0.98 | 0.58 | 0.63 | 2.65 | 2.39 | 1.89 | 2.02 | 1.50 | -60.91 |
P/FCF Ratio | -1.05 | -1.09 | -2.64 | -2.59 | -2.16 | -2.13 | -4.7 | -5.92 | -107.11 |
P/OCF Ratio | -1.06 | -1.1 | -2.64 | -2.65 | -2.17 | -2.21 | -4.72 | -5.95 | -107.11 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.02 | 0.01 | 0.00 | 0.02 | 0.02 | n/a | n/a | 0.02 | -0.6 |
Quick Ratio | 3.86 | 9.47 | 20.03 | 5.25 | 3.16 | 2.06 | 3.75 | 3.88 | 0.04 |
Current Ratio | 3.86 | 9.46 | 20.02 | 5.89 | 3.78 | 2.06 | 3.75 | 3.88 | 0.04 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -89.86 | n/a |
Return on Equity (ROE) | -1.14 | -0.53 | -0.11 | -0.84 | -0.85 | -0.83 | -0.57 | -0.26 | 1.00 |
Return on Assets (ROA) | -0.78 | -0.48 | -0.11 | -0.52 | -0.52 | -0.61 | -0.5 | -0.24 | -26.64 |
Return on Capital (ROIC) | -0.94 | -0.58 | -0.29 | -0.76 | -0.81 | -0.96 | -0.5 | -0.26 | 0.99 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |